Clinical Trial Update: Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

View source ↗

Summary

A completed Boehringer Ingelheim-sponsored clinical trial update reports longitudinal biomarker data that may predict emphysema progression in patients with chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Emphysema

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema | Status: COMPLETED | Results posted: 2024-08-16